Zantifar Dosage & Drug Information

Concise Prescribing Info Bahasa Concise Prescribing Info

Concise Prescribing Info

Contents

Ranitidine HCl

Indications/Uses

Short-term treatment of acute gastric & duodenal ulcers, reflux esophagitis & pathological hypersecretory conditions (eg, Zollinger-Ellison syndrome).

Dosage/Direction for Use

Adult Gastric & duodenal ulcer, reflux esophagitis 1 tab twice daily or 2 tab as a single dose before bedtime for 4-8 wk. Pathological hypersecretory condition 1 tab 2-3 times daily. Acute peptic ulcer Maintenance dose: 1 tab/day at night. Impaired kidney function CrCl <50 mL/min 150 mg/day.

Administration

May be taken with or without food.

Special Precautions

Long-term use. Impaired liver & kidney function. Pregnancy & lactation. Childn.

Adverse Reactions

Constipation, dizziness, abdominal pain, increased serum creatinine level, transient increase in serum transaminase & α-glutamyl transpeptidase.

View ADR Monitoring Form

Drug Interactions

May enhance suppression of gastric acid secretion w/ antimuscarinic agents.

MIMS Class

Antacids, Antireflux Agents & Antiulcerants

ATC Classification

A02BA02 - ranitidine ; Belongs to the class of H2-receptor antagonists. Used in the treatment of peptic ulcer and gastro-oesophageal reflux disease (GERD).

Regulatory Classification

Presentation/Packing

Form

Zantifar film-coated tab 150 mg

Packing/Price

5 × 10's (Rp35,244/boks)

Zantifar

ranitidine

Manufacturer:

Ifars